Leyden Labs
Leiden, NL · Founded 2020 · 80 employees on LinkedIn · 13 known investors
Find your way into Leyden Labs
2,245 people in our graph share verified history with the Leyden Labs team — schools, employers, funds. One of them is your warm intro.
Laura Buhlerunlockedknows Koenraad Wiedhaup · together at McKinsey & Company (overlapped)
knows the team · via University of Amsterdam
×8knows the team · via McKinsey & Company
knows the team · via Columbia Business School
knows the team · via Galapagos
Leyden Labs develops nasal sprays containing antibodies that target respiratory viruses such as influenza and COVID at the nasal mucosa to prevent initial infection and transmission. The company works on broadly protective antiviral products aimed at addressing endemic and pandemic respiratory threats.
Founders & leadership
Leyden Labs was founded in 2020 by Koenraad Wiedhaup, Ronald Brus, Jaap Goudsmit, and Dinko Valerio.
KW
Koenraad WiedhaupinFounder & Chief Executive OfficerKoenraad Wiedhaup is founder and CEO of Leyden Labs, which develops antibody-based nasal sprays targeting respiratory viruses. He previously worked as a partner at McKinsey & Company advising life sciences companies, and began his career at a biotech firm in the San Francisco Bay Area; he holds degrees in life sciences and biotechnology from the Universities of Leiden and Delft.
RB
Ronald BrusinFounder & Chief Growth OfficerPhysician and entrepreneur who founded myTomorrows and co-founded Leyden Labs and Eyro.ai; previously held leadership roles including CEO and COO at Crucell and served on the Executive Committee of Galapagos; earned an MD from the University of Groningen.
JG
Jaap GoudsmitinFounding Scientist and Senior Advisor
DV
Dinko ValerioinFounder and Chair of the Supervisory BoardDinko Valerio is founder and chair of Leyden Labs, which develops nasal sprays containing antibodies to prevent respiratory viral infection. He previously founded and served as CEO of Crucell, a vaccine-focused biotechnology company, and co-founded Galapagos Genomics and the venture capital firm Aescap Venture; he earned a Ph.D. with honors from the University of Leiden and held a professorship in gene therapy there.
JA
Jintanat AnanworanichinChief Medical OfficerJintanat Ananworanich is a pediatrician and clinical immunologist with expertise in infectious diseases and vaccine clinical research. He serves as Chief Medical Officer of Leyden Labs, which develops nasal spray antibodies to prevent respiratory viral infections.
CK
Clarissa KochinChief Scientific Officer
MV
Marieke van der LansinChief Financial Officer
XM
Xavier MaesinGeneral Counsel
RT
Rosemary TanChief Executive Officer, Leyden Labs Asia
Investors · 13
ClavystBio✓ verifiedSingapore
F-Prime Capital✓ verifiedCambridge · $3M – $10M
GV (Google Ventures)✓ verifiedMountain View · $250K – $50M
Bluebird Ventures✓ verifiedPalo Alto
Casdin Capital✓ verifiedNew York
European Innovation Council Fund✓ verified
European Investment Bank✓ verifiedLuxembourg
Invest-NL✓ verifiedAmsterdam
Invus✓ verifiedNew York
Polaris Partners✓ verifiedBoston · $500K – $5M
Qiming Venture Partners✓ verifiedBeijing · $5M – $134M
Connecticut InnovationsNew Haven · $500K – $2M
Also in the syndicate · 1
Gates Foundation
Founder mafia
2 people who came through Leyden Labs went on to found or lead other companies.
Competitors · 5
by search overlap
Linden Lab7 shared keywordsLinden Lab operates Second Life, a virtual world where users can create, socialize, and conduct economic activity, and Tilia, a licensed money services business that facilitates virtual economy transactions.
Denali Therapeutics7 shared keywordsDenali Therapeutics develops therapeutics for neurodegenerative diseases. The company focuses on discovering and developing novel drug candidates targeting specific neurological conditions.
Greentownlabs5 shared keywordsGreentown Labs is a climatetech startup incubator that supports and houses early-stage entrepreneurs, connecting them with corporate partners, investors, and community resources to develop and commercialize energy and climate technologies. It operates locations in Boston and Houston in the United States.
Getlabs5 shared keywordsGetlabs provides at-home lab sample collection, sending phlebotomists to patients to draw blood and collect samples for lab tests ordered by their providers. Lab results are shared directly with the patient and the ordering provider, with support for connecting results to the Apple Health app.
Enliven Therapeutics4 shared keywordsEnliven Therapeutics is a clinical-stage biopharmaceutical company that discovers and develops small molecule therapeutics using a precision medicine approach, with a focus on oncology and hematology. Its discovery work combines clinically validated biological targets with differentiated chemistry to develop drugs for unmet medical needs.
Companies competing with Leyden Labs for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Leyden Labs do?
- Leyden Labs develops nasal sprays containing antibodies that target respiratory viruses such as influenza and COVID at the nasal mucosa to prevent initial infection and transmission. The company works on broadly protective antiviral products aimed at addressing endemic and pandemic respiratory threats.
- Who founded Leyden Labs?
- Leyden Labs was founded by Koenraad Wiedhaup, Ronald Brus, Jaap Goudsmit, Dinko Valerio in 2020.
- Who are Leyden Labs's investors?
- Leyden Labs's investors include ClavystBio, F-Prime Capital, GV (Google Ventures), Bluebird Ventures, Casdin Capital, European Innovation Council Fund, European Investment Bank, Invest-NL and 4 more.
- Where is Leyden Labs headquartered?
- Leyden Labs is headquartered in Leiden, NL.